Document Classification

Section Type: RESULTS

Text: Among 1687 patients treated with BMS who were randomized to continued thienopyridine vs placebo, rates of stent thrombosis were 0. 5 % vs 1. 11 % (n = 4 vs 9 ; hazard ratio [HR], 0. 49 ; 95 % CI, 0. 15-1. 64 ; P =. 24), rates of MACCE were 4. 04 % vs 4. 69 % (n = 33 vs 38 ; HR, 0. 92 ; 95 % CI, 0. 57-1. 47 ; P =. 72), and rates of moderate/severe bleeding were 2. 03 % vs 0. 90 % (n = 16 vs 7 ; P =. 07), respectively.